Profile data is unavailable for this security.
About the company
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.
- Revenue in USD (TTM)4.57bn
- Net income in USD615.95m
- Incorporated1947
- Employees16.70k
- LocationPerkinElmer Inc940 Winter StreetWALTHAM 02451United StatesUSA
- Phone+1 (781) 663-5776
- Websitehttps://www.perkinelmer.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Badger Meter Inc | 565.57m | 66.50m | 3.52bn | 1.84k | 53.19 | 7.97 | 38.00 | 6.23 | 2.26 | 2.26 | 19.26 | 15.12 | 0.9976 | 3.15 | 7.94 | -- | 11.73 | 10.88 | 14.13 | 12.94 | 38.89 | 39.05 | 11.76 | 10.69 | 2.07 | -- | -- | 40.71 | 11.95 | 7.04 | 9.22 | 13.46 | -17.13 | 11.65 |
| Vontier Corp | 3.10bn | 446.00m | 3.70bn | 8.50k | 8.72 | 7.44 | 6.58 | 1.19 | 2.68 | 2.68 | 18.90 | 3.15 | 0.7357 | 5.31 | 6.30 | 365,023.50 | 10.57 | -- | 13.35 | -- | 45.11 | 43.47 | 14.37 | 14.32 | 1.10 | 9.79 | 0.841 | 0.6505 | 10.58 | 4.60 | 20.76 | 6.27 | -- | -- |
| Integra Lifesciences Holdings Corp | 1.57bn | 172.99m | 4.97bn | 3.80k | 28.96 | 2.88 | 16.98 | 3.17 | 2.05 | 2.05 | 18.57 | 20.65 | 0.4129 | 1.81 | 6.45 | 411,886.30 | 4.56 | 3.26 | 4.98 | 3.61 | 63.18 | 64.21 | 11.05 | 7.36 | 2.91 | 7.05 | 0.4723 | 0.00 | 12.43 | 9.23 | 26.28 | 17.79 | 0.3158 | -- |
| MKS Instruments Inc | 3.22bn | 429.20m | 6.92bn | 6.00k | 13.54 | 1.67 | 11.99 | 2.15 | 7.69 | 7.69 | 56.48 | 62.39 | 0.4098 | 2.39 | 5.48 | 537,483.30 | 5.45 | 11.30 | 6.01 | 12.58 | 43.92 | 45.93 | 13.31 | 15.91 | 1.81 | 7.11 | 0.5459 | 12.14 | 26.59 | 17.89 | 57.50 | 39.38 | 35.30 | 4.81 |
| Cognex Corporation | 1.01bn | 213.75m | 9.42bn | 2.26k | 44.97 | 6.78 | 40.37 | 9.32 | 1.21 | 1.21 | 5.73 | 8.03 | 0.5119 | 2.99 | 8.58 | 447,816.60 | 10.83 | 15.17 | 11.80 | 16.40 | 71.96 | 74.27 | 21.15 | 28.48 | 4.21 | -- | 0.00 | 44.87 | 27.88 | 14.39 | 58.86 | 14.22 | 3.82 | 10.68 |
| Bruker Corporation | 2.51bn | 274.90m | 10.50bn | 7.77k | 39.07 | 11.22 | 28.90 | 4.19 | 1.83 | 1.83 | 16.64 | 6.36 | 0.7752 | 1.65 | 6.32 | 322,704.40 | 8.54 | 7.68 | 11.87 | 10.50 | 51.19 | 47.94 | 11.01 | 9.57 | 1.49 | 30.95 | 0.5475 | 12.96 | 21.66 | 8.46 | 75.60 | 12.53 | 19.92 | 0.00 |
| Bio Rad Laboratories Inc | 2.80bn | -6.03bn | 13.67bn | 7.90k | -- | 1.66 | -- | 4.87 | -201.80 | -201.80 | 93.97 | 283.45 | 0.1752 | 1.93 | 6.60 | 355,029.10 | -37.70 | 24.42 | -39.20 | 26.36 | 56.17 | 55.45 | -215.16 | 83.24 | 4.30 | 0.056 | 0.1241 | 0.00 | 14.81 | 7.16 | 11.55 | 177.08 | -3.10 | -- |
| Avantor Inc | 7.51bn | 662.30m | 16.45bn | 13.50k | 25.04 | 3.39 | 15.41 | 2.19 | 0.9745 | 0.9745 | 11.06 | 7.20 | 0.5491 | 5.50 | 6.16 | -- | 5.02 | 2.45 | 5.66 | 2.76 | 34.65 | 32.91 | 9.14 | 4.09 | 1.05 | 4.34 | 0.5643 | -- | 1.71 | 43.20 | 30.37 | -- | 39.56 | -- |
| PerkinElmer, Inc. | 4.57bn | 615.95m | 17.60bn | 16.70k | 28.64 | 2.49 | 16.54 | 3.85 | 4.86 | 4.99 | 36.06 | 55.98 | 0.3179 | 4.03 | 6.13 | 273,361.60 | 4.29 | 6.63 | 4.72 | 7.70 | 54.80 | 52.31 | 13.49 | 14.32 | 1.84 | 8.45 | 0.3839 | 6.55 | 33.95 | 19.09 | 29.55 | 34.32 | 25.80 | 0.00 |
| Waters Corporation | 2.95bn | 696.93m | 20.33bn | 7.80k | 29.85 | 52.90 | 24.50 | 6.89 | 11.47 | 11.47 | 48.57 | 6.47 | 0.9537 | 3.01 | 5.20 | 378,191.70 | 22.53 | 16.20 | 29.15 | 19.44 | 57.59 | 58.48 | 23.63 | 24.16 | 1.55 | 23.49 | 0.8004 | 0.00 | 17.78 | 5.15 | 32.84 | 5.85 | 12.12 | -- |
| Fortive Corp | 5.83bn | 755.20m | 24.39bn | 18.00k | 32.96 | 2.52 | 19.97 | 4.19 | 2.10 | 2.10 | 16.15 | 27.44 | 0.3601 | 4.69 | 6.17 | -- | 4.67 | 4.68 | 5.83 | 5.78 | 57.73 | 56.68 | 12.96 | 14.79 | 0.7115 | 10.28 | 0.2513 | 14.36 | 10.87 | 0.2407 | 30.27 | -1.50 | -2.92 | 0.00 |
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2022 | 14.31m | 11.33% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2022 | 13.70m | 10.85% |
| The Vanguard Group, Inc.as of 30 Sep 2022 | 13.56m | 10.74% |
| Select Equity Group LPas of 30 Sep 2022 | 8.76m | 6.93% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 5.87m | 4.65% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 5.20m | 4.12% |
| Massachusetts Financial Services Co.as of 30 Sep 2022 | 3.98m | 3.15% |
| Pictet Asset Management SAas of 30 Sep 2022 | 2.80m | 2.22% |
| Geode Capital Management LLCas of 30 Sep 2022 | 2.48m | 1.97% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2022 | 2.26m | 1.79% |
